an account was given of the current status of treatment of renal cell carcinoma and reference made to problems that remain unsolved as follows : ( 1 ) failure to keep biological characteristics of renal cell carcinoma in mind may be misleading in deciding on a therapeutic policy , ( 2 ) already established as it may appear , operation for renal cell carcinoma is still open to discussion , ( 3 ) indication for operation upon metastatic lesions , ( 4 ) widespread use of interferon based on insufficient theoretical grounds to provide ample justification , ( 5 ) future development and possible usefulness of multiple drug combination therapy including interferon as a main component and ( 6 ) how to make best use of neo-adjuvant therapy for renal cell carcinoma .
C0021747
interferon
C0007134
renal cell carcinoma